• Machine Learning Discovery of Senolytics: Key Findings

  2026-09-14

  The reference study shows that cost-effective machine-learning models trained only on published screening data can identify senolytic candidates from chemical libraries. Its validation of ginkgetin, periplocin, and oleandrin illustrates how computational prioritization can reduce early screening costs while preserving the need for cell-based selectivity and mechanism studies.

• Angiotensin 1/2 (5-7): From RAS to Translation

  2026-09-14

  A mechanistic and translational guide to using Angiotensin 1/2 (5-7) as a sequence-defined probe in renin-angiotensin system research, hypertension models, and emerging SARS-CoV-2 spike–receptor binding studies.

• BCA Protein Quantification Kit K4102 Guide

  2026-09-13

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports total-protein measurement in dilute samples, cell lysates, and many detergent-containing biochemical preparations. It is intended for scientific research workflows and should not be used for diagnostic, clinical, or medical testing.

• Nebivolol: Precision in β1 Signaling Research

  2026-09-12

  Nebivolol hydrochloride offers a precise pharmacological entry point for dissecting β1-adrenergic receptor signaling, while recent yeast-based mTOR screening provides a valuable boundary condition: absence of TOR inhibition in that model should not be mistaken for universal pathway inactivity. This article translates both findings into a rigorous experimental strategy.

• JHU-083 Workflows for Glutaminase Research

  2026-09-11

  JHU-083 provides a practical way to investigate glutaminase-dependent glutamate biology in cerebral CD11b cells and experimental cerebral malaria models. This workflow guide combines cell-selective pathway perturbation with glutamate, viability, and redox measurements for more defensible neurological disease experiments.

• Live-Dead Cell Staining Kit: Translational Insight

  2026-09-11

  A mechanistic and strategic guide to using Calcein-AM and Propidium Iodide staining to strengthen biomaterial, drug-delivery, and cytotoxicity decisions. Anchored to research on a thermosensitive hydrogel for erythromycin delivery in bacterial keratitis, the article explains how viability data can move beyond descriptive imaging toward translationally useful evidence.

• Live-Dead Cell Staining Kit in Ferroptosis Research

  2026-09-10

  The Live-Dead Cell Staining Kit links membrane integrity and esterase activity to practical viability decisions in oxidative-stress research. Learn how Calcein-AM Propidium Iodide staining complements ferroptosis, inflammation, microscopy, and flow cytometry assays.

• Prochlorperazine: Applied Research Workflows

  2026-09-10

  Learn how to use Prochlorperazine as a dopamine D2 receptor antagonist in melanoma, endocytosis, and translational antiemetic research. This workflow-driven guide covers dose selection, controls, assay design, troubleshooting, and how the acute mountain sickness trial protocol informs prophylactic study planning.

• 3-Hydroxybutyrate (BHBA): A Causal Assay Framework

  2026-09-09

  3-Hydroxybutyrate (BHBA) is more than a ketosis marker: it is a metabolic, membrane, and chromatin perturbation tool. This article presents a causal assay framework for connecting BHBA exposure with ferroptosis, energy metabolism, and histone regulation while avoiding overinterpretation of broader ketone-body evidence.

• RG108 Pharmacokinetics in Rats

  2026-09-09

  The reference study evaluated whether the non-nucleosidic DNA methyltransferase inhibitor RG108 could achieve measurable systemic and tissue exposure after subcutaneous administration in rats. Its pharmacokinetic profile, including rapid absorption, an approximately 3.7-hour terminal half-life, and detectable heart and liver levels, supports RG108 as a tool for exploratory in vivo DNMT inhibition while leaving efficacy and long-term safety questions open.

• Sex Differences in Cannabinoid Withdrawal in Rats

  2026-09-08

  Brewer and colleagues show that withdrawal from WIN 55,212-2 produces sex- and time-dependent differences in somatic and anxiety-related behaviors, with rimonabant revealing distinct withdrawal thresholds and behavioral profiles in male and female rats. The study’s component-level analysis and combined precipitated and spontaneous withdrawal design provide a useful framework for interpreting cannabinoid dependence models.

• Azithromycin B1398 for Reliable Cell Assays

  2026-09-08

  Learn how Azithromycin (SKU B1398) can support bacterial infection research, resistance testing, and carefully controlled cell viability workflows. This scenario-driven guide covers solvent compatibility, assay controls, interpretation, storage, and practical product-selection criteria.

• Nebivolol hydrochloride for β1 Signaling Research

  2026-09-07

  Nebivolol hydrochloride offers a potent, selective way to interrogate β1-adrenergic receptor signaling without treating a negative mTOR result as proof of pathway activity. This workflow combines receptor-proximal cardiovascular assays with a sensitized yeast counter-screen to improve mechanistic confidence and troubleshoot compound-specific artifacts.

• DNase I: From Clean RNA to Better PDAC Models

  2026-09-07

  A mechanistic and translational guide to using RNase-free DNase I for DNA removal, RNA integrity, RT-PCR confidence, and more reproducible patient-derived pancreatic cancer models.

• Cell Death in Liver Disease: Mechanisms and Relevance

  2026-09-05

  Luedde, Kaplowitz, and Schwabe frame hepatocyte death as a central driver of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma rather than merely a passive marker of liver injury. Their review distinguishes apoptosis, necrosis, and necroptosis, connects each mode to damage-associated responses, and clarifies how clinical biomarkers and experimental models can guide therapeutic research.

8539 records 1/570 page Next 12345 下5页 Last page